Zhejiang Hisoar Pharmaceutical Co.,Ltd.’s Net Profit Rose 185.8% in First Half of 2022

Zhejiang Hisoar Pharmaceutical Co.,Ltd. (浙江海翔药业股份有限公司) (002099.SZ) reported a net profit of 170.8 million yuan in the first half of 2022, up 185.8% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, up 23.5% year-on-year.

At the end of the reporting period, it had 8.4 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 26.7%.